ESEduardo Silva

Eduardo Silva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eduardo Silva has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pedal acceleration time as a diagnostic and prognostic tool in peripheral artery disease: systematic review and meta-analysis

    by Mariana Rosado-Fonseca, Eduardo Silva, Tiago Ribeiro, Antónia Rocha-Melo, Daniela Santos-Silva, Mário Marques-Vieira, Piotr Myrcha, Hugo Ribeiro, João Rocha-Neves

    Background: Wound healing in chronic limb-threatening ischaemia in peripheral artery disease (PAD) remains clinically challenging. Accurate perfusion assessment may predict limb outcomes. Standard measures ankle-brachial index (ABI) and transcutaneous oxygen pressure have limitations. The ABI, the guideline-recommended first-line diagnostic tool, has well-recognised limitations in patients. Pedal acceleration time (PAT), measured by duplex ultrasound from onset to peak arterial systole in the pedal arteries, shows promise as a prognostic marker, though its diagnostic and prognostic performance has not been fully validated. This study aimed to perform a systematic review and meta-analysis evaluating PAT’s diagnostic accuracy compared with ABI in detecting lower-limb ischaemia. Secondary objectives included assessing PAT’s prognostic value for wound healing and amputation risk. Methods: Three electronic databases MEDLINE, Scopus, and Web of Science, were systematically searched for studies evaluating PAT values and wound healing in PAD patients. Wound healing incidence and PAT-ABI correlations were pooled according to Preferred Reporting Items for Systematic reviews and Meta-Analyses of Diagnostic Test Accuracy studies (PRISMA-DTA) guidelines. Pooled diagnostic indices, including sensitivity, specificity, positive and negative likelihood ratios, and diagnostic odds ratio with 95% confidence intervals were calculated. Study quality was assessed using the National Heart, Lung, and Blood Institute (NHLBI) Study Quality Assessment Tool for observational cohort and cross-sectional designs. Results: Seventeen studies (1749 patients) were included as following: 8 cross-sectional, 1 observational prospective, 3 observational retrospective, 4 cohort (3 retrospective, 1 prospective), and 1 case-control study. PAT demonstrated good diagnostic accuracy with pooled 0.72 (95% CI 0.68–0.76) sensitivity, 0.84 (95% CI 0.79–0.88) specificity, 4.38 (95% CI 3.35–5.73) positive likelihood ratio, 0.25 (95% CI 0.19–0.33) negative likelihood ratio, and 14.85 (95% CI 10.02–22.01) diagnostic odds ratio, indicating robust discrimination compared to ABI. The selected studies, referring to the period 2019–2025, reported an association between higher PAT values and worse wound healing outcomes and increased amputation risk. Due to insufficient and non-standardised data, PAT’s prognostic pooled analysis for wound healing was not feasible. Conclusion: PAT accurately detected clinically significant lower-limb ischaemia compared to ABI. Faster PAT values correlated to higher ABI and favorable wound healing outcomes, whereas prolonged PAT indicated higher risk of non-healing wounds and major amputation. These results support PAT as a useful duplex-based complement to existing perfusion tests.


  • Open Access

    Infected Thrombosed Popliteal Artery Aneurysm With Cutaneous Fistula

    by Leonor Baldaia, Tiago Oliveira, Eduardo Silva, Joana Moreira, Luís F. Antunes

  • Open Access

    Aneurysmal Degeneration of the Brachial Artery Following Chronic Arteriovenous Fistula Ligation

    by Eduardo Silva, Celso Nunes, Leonor Baldaia, Miguel Castro, Luís Orelhas, Juliana Varino, Luís F. Antunes

  • Open Access

    Treatment of coral reef aorta with descending thoracic aorta bypass: A case report and literature review

    by Celso Nunes, Ricardo V. Pereira, João O'NEill Pedrosa, Vânia Oliveira, Eduardo Silva, Leonor Baldaia, Miguel Silva, Gabriel Anacleto

  • Open Access

    Giant Sac Growth: A Hybrid Approach to Treat a Misdiagnosed Late Type IIIb Endoleak

    by Eduardo Silva, Celso Nunes, Leonor Baldaia, Miguel Castro, Vânia Constâncio Oliveira, Joana Silva, Luís F. Antunes


  • Open Access

    Acute Limb Ischaemia: Charlson Comorbidity Index Adjusted to Age, Biomarkers, and Prognosis

    by Vânia Constâncio Oliveira, Pedro Lima, Joana Cruz Silva, Celso Nunes, Eduardo Silva, Ricardo Vale Pereira, Manuel Fonseca

  • Open Access

    A multinodular goiter as the initial presentation of a renal cell carcinoma harbouring a novel VHL mutation

    by Maria João M Bugalho, Evelina Mendonça, Patrícia Costa, Jorge Rosa Santos, Eduardo Silva, Ana Luísa Catarino, Luís G Sobrinho

    Secondary involvement of the thyroid gland is rare. Often the origin of the tumor is difficult to identify from the material obtained by fine-needle aspiration cytology. Renal cell carcinoma of the clear-cell type is one of the more common carcinomas to metastasize to the thyroid gland. Somatic mutations of the von Hippel-Lindau tumor suppressor gene are associated with the sporadic form of this tumor. We aimed to illustrate the potential utility of DNA based technologies to search for specific molecular markers in order to establish the anatomic site of origin. A 54-yr-old Caucasian male complaining of a rapidly increasing neck tumor was diagnosed as having a clear-cell tumor by fine-needle aspiration cytology. A positive staining for cytokeratin as well as for vimentin and CD10 in the absence of staining for thyroglobulin, calcitonin and TTF1 suggested a renal origin confirmed by computed tomography. Using frozen RNA, obtained from cells left inside the needle used for fine needle aspiration cytology, it was possible to identify a somatic mutation (680 delA) in the VHL gene. In the presence of a clear-cell tumor of the thyroid gland, screening for somatic mutations in the VHL gene in material derived from thyroid aspirates might provide additional information to immunocytochemical studies and therefore plays a contributory role to establish the final diagnosis. Moreover, in a near future, this piece of information might be useful to define a targeted therapy.